// App-Quantinova.ai

: Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study

Researchers

Presenter

  • Nikolai Podoltsev

Principal Investigators

  • Mengxin Zhu

  • Rong Wang

  • Amer M. Zeidan

  • Xiaoyi Wang

  • Scott F Huntington

  • Smith Giri

  • Amy J. Davidoff

  • Steven D. Gore

  • Xiaomei Ma

Medical Centers

  • Dept of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT

  • Yale Cancer Center, Yale School of Medicine, New Haven, CT

  • Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, CT

  • Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT

  • Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, United States

  • Dept of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Essential thrombocythemia

  • Venous thrombosis

  • Influenza

Biomarkers

  • N/A

Drug/Treatment

  • Atorvastatin

  • Pitavastatin

  • Rosuvastatin

  • Fluvastatin

  • Hydroxyurea

  • Hydroxycarbamide

  • Simvastatin

  • Pravastatin sodium

  • Lavastatin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved